Changes in growth hormone and prolactin release after superior cervical ganglionectomy of rats

Superior cervical ganglionectomy (SCG×) decreased significantly serum growth hormone (GH) levels in rats 14-96 h after surgery, during and immediately after anterograde degeneration of regional sympathetic terminals. At later times (up to 28 days after SCG×) an increase in serum GH was observed. SCG...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Cardinali, D.P
Otros Autores: Boado, R.J, Vacas, M.I, Deza, S.
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1986
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 07726caa a22010817a 4500
001 PAPER-18154
003 AR-BaUEN
005 20230518204931.0
008 190411s1986 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0022651070 
024 7 |2 cas  |a growth hormone, 36992-73-1, 37267-05-3, 66419-50-9, 9002-72-6; phenoxybenzamine, 59-96-1, 63-92-3; prolactin, 12585-34-1, 50647-00-2, 9002-62-4; propranolol, 13013-17-7, 318-98-9, 3506-09-0, 4199-09-1, 525-66-6; Growth Hormone, 9002-72-6; Phenoxybenzamine, 59-96-1; Prolactin, 9002-62-4; Propranolol, 525-66-6; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a BRREA 
100 1 |a Cardinali, D.P. 
245 1 0 |a Changes in growth hormone and prolactin release after superior cervical ganglionectomy of rats 
260 |c 1986 
270 1 0 |m Cardinali, D.P.; Centro de Estudios Farmacológicos y de Principios Naturales, CEFAPRIN, CONICET, Buenos Aires, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Almgren, Dahlstrom, Ha¨ggendal, Degeneration secretion and noradrenaline disappearance in rat salivary glands following proximal or distal axotomy (1976) Acta Physiol. Scand., 98, pp. 457-464 
504 |a Arimura, Merchenthaler, Culler, Iwasak, Distribution and release of GRF (1984) Endocrinology, pp. 827-830. , F. Labrie, L. Prouxl, Elsevier, Amsterdam 
504 |a Cardinali, Ladizesky, Changes in parathyroid hormone release and calcium levels after superior cervical ganglionectomy of rats (1985) Neuroendocrinology, 40, pp. 291-296 
504 |a Cardinali, Nagle, Gomez, Rosner, Norepinephrine turnover in the rat pineal gland. Acceleration by estradiol and testosterone (1975) Life Sci., 16, pp. 1717-1724 
504 |a Cardinali, Pisarev, Barontini, Juvenal, Boado, Vacas, Efferent neuroendocrine pathways of sympathetic superior cervical ganglia. Early depression of the pituitary-thyroid axis after ganglionectomy (1982) Neuroendocrinology, 35, pp. 248-254 
504 |a Cardinali, Vacas, Fortis, Stefano, Superior cervical ganglionectomy depresses norepinephrine uptake, increases the density of α-adrenergic sites, and induces supersensitivity to adrenergic drugs in rat medial basal hypothalamus (1981) Neuroendocrinology, 33, pp. 199-206 
504 |a Cella, Morgese, Mantegazza, Mu¨ller, Inhibitory action of theα1-adrenergic receptor on growthormone secretion in the dog (1984) Endocrinology, 114, pp. 2406-2408 
504 |a Chiocchio, Cardinali, Vacas, Tramezzani, Acute superior cervical ganglionectomy depresses the postcastration rise of gonadotropins in male rats (1984) Brain Research, 309, pp. 354-357 
504 |a Ebadi, Regulation of the synthesis of melatonin and its significance to neuroendocrinology (1984) The Pineal Gland, pp. 1-38. , R.J. Reiter, Raven Press, New York 
504 |a Emmelin, Trendelenburg, Degeneration activity after parasympathetic or sympathetic denervation (1972) Rev. Physiol. Biochem. Exp. Pharmacol., 66, pp. 148-204 
504 |a Krulich, Central neurotransmitters and the secretion of prolactin, GH, Land TSH (1979) Annu. Rev. Physiol., 41, pp. 603-615 
504 |a Krulich, Mayfield, Steele, Millen, McCann, Koenig, Differential effects of pharmacological manipulations of centralα1andα2-adrenergic receptors on the secretion of thyrotropin and growthormone in male rats (1982) Endocrinology, 110, pp. 796-804 
504 |a Lipinska, Orlowska-Majdak, Traczyk, Oxytocin release from neurohypophysis evoked by preganglionic stimulation of the rat superior servical ganglion (1982) Endokrinologie, 79, pp. 385-392 
504 |a Martin, Brain regulation of Gsecretion (1976) Frontiers in Neuroendocrinology, 4, pp. 129-156. , L. Martini, W.F. Ganong, Raven Press, New York 
504 |a Nahmod, Balda, Pirola, Cardinali, Changes in plasma aldosterone and renin activity after bilateral superior cervical ganglionectomy in two strains of rats (1984) Acta Physiol. Pharmacol. Lat. Am., 34, pp. 263-269 
504 |a U'Prichard, Greenberg, Snyder, Binding characteristics of radiolabelled agonist and antagonist of central nervous system alpha noradrenergic receptors (1977) Mol. Pharmacol., 13, pp. 454-462 
520 3 |a Superior cervical ganglionectomy (SCG×) decreased significantly serum growth hormone (GH) levels in rats 14-96 h after surgery, during and immediately after anterograde degeneration of regional sympathetic terminals. At later times (up to 28 days after SCG×) an increase in serum GH was observed. SCG× augments prolactin (PRL) release, but only at the earliest time examined (14 h after surgery). Injection of the α-adrenoceptor blocker, phenoxybenzamine, but not of the β-blocker, propranolol, negated the depression in serum GH found in SCG× rats 14 h after surgery, without affecting PRL release. © 1986.  |l eng 
536 |a Detalles de la financiación: 1/60 288 
536 |a Detalles de la financiación: This work was supported by grants from the Con-sejo Nacional de Investigaciones Cientfficas y T6cni-cas (CONICET), Argentina, and the Stiftung Volks-wagenwerk, Hannover (F.R.G., Grant 1/60 288). D.P.C., R.J.B. and M.I.V. are established investigators from CONICET. 
593 |a Centro de Estudios Farmacológicos y de Principios Naturales, CEFAPRIN, CONICET, Buenos Aires, Argentina 
690 1 0 |a DEGENERATION ACTIVITY 
690 1 0 |a GROWTH HORMONE 
690 1 0 |a NORADRENALINE 
690 1 0 |a PROLACTIN 
690 1 0 |a SUPERIOR CERVICAL GANGLION 
690 1 0 |a Α-ADRENOCEPTOR 
690 1 0 |a Β-ADRENOCEPTOR 
690 1 0 |a ADRENERGIC RECEPTOR 
690 1 0 |a ALPHA ADRENERGIC RECEPTOR 
690 1 0 |a BETA ADRENERGIC RECEPTOR 
690 1 0 |a GROWTH HORMONE 
690 1 0 |a PHENOXYBENZAMINE 
690 1 0 |a PROLACTIN 
690 1 0 |a PROPRANOLOL 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a AUTONOMIC NERVOUS SYSTEM 
690 1 0 |a BLOOD AND HEMOPOIETIC SYSTEM 
690 1 0 |a DRUG COMPARISON 
690 1 0 |a DRUG EFFICACY 
690 1 0 |a DRUG MECHANISM 
690 1 0 |a ENDOCRINE SYSTEM 
690 1 0 |a GANGLIONECTOMY 
690 1 0 |a HORMONE RELEASE 
690 1 0 |a HYPOPHYSIS 
690 1 0 |a NONHUMAN 
690 1 0 |a PRELIMINARY COMMUNICATION 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a RAT 
690 1 0 |a SUBCUTANEOUS DRUG ADMINISTRATION 
690 1 0 |a SUPERIOR CERVICAL GANGLION 
690 1 0 |a ANIMAL 
690 1 0 |a GANGLIA, SYMPATHETIC 
690 1 0 |a GROWTH HORMONE 
690 1 0 |a MALE 
690 1 0 |a PHENOXYBENZAMINE 
690 1 0 |a PITUITARY GLAND, ANTERIOR 
690 1 0 |a PROLACTIN 
690 1 0 |a PROPRANOLOL 
690 1 0 |a RATS 
690 1 0 |a RATS, INBRED STRAINS 
690 1 0 |a RECEPTORS, ADRENERGIC, ALPHA 
690 1 0 |a RECEPTORS, ADRENERGIC, BETA 
690 1 0 |a SUPPORT, NON-U.S. GOV'T 
690 1 0 |a SYMPATHECTOMY 
700 1 |a Boado, R.J. 
700 1 |a Vacas, M.I. 
700 1 |a Deza, S. 
773 0 |d 1986  |g v. 363  |h pp. 350-353  |k n. 2  |p Brain Res.  |x 00068993  |w (AR-BaUEN)CENRE-4052  |t Brain Research 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022651070&doi=10.1016%2f0006-8993%2886%2991021-8&partnerID=40&md5=c32260ac4a9a65eeca74f2896058db3c  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/0006-8993(86)91021-8  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00068993_v363_n2_p350_Cardinali  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00068993_v363_n2_p350_Cardinali  |y Registro en la Biblioteca Digital 
961 |a paper_00068993_v363_n2_p350_Cardinali  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 79107